Skip to content

DEVA PHARMA

Active Risk: not assessed Private limited companyfounded 2012active for 14 yearsRidder de Ghellinckstraat 28, 8710 WielsbekeKBO/BCE: BE 0847.315.091

Timeline

23 events since 2012

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 32 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0847315091
Annual accounts 2024 filed PDFabbreviated format · 30 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 29 days before the deadline
Change of role: Muriel DEBEUCKELAERE, from manager to directorDirector discharge: Muriel DEBEUCKELAERE · General meeting of 25-01-20246 points ▸
  • General meeting, 25-01-2024
  • Registered office clause, Ridder de Ghellinckstraat 28, 8710 Wielsbeke
  • Director resignation, Muriel DEBEUCKELAERE (manager)
  • Director appointment, Muriel DEBEUCKELAERE (director (not named in the articles))
  • Director discharge, Muriel DEBEUCKELAERE
  • 186 shares
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2023
Highest result from 2013 to 2025 net €102,411 ▲33% The operating result of €156,157 and the net result of €102,411 are both a record.
Equity above €500,000 equity €545,895 ▲11.6% With a profit in every financial year since 2013, equity grows to €545,895.
Annual accounts 2022 filed PDFabbreviated format · 28 days before the deadline
2022
Annual accounts 2021 filed PDFabbreviated format · 20 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 25 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 25 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 8 days before the deadline
2018
Equity above €200,000 equity €238,663 ▲28.2% With a profit in every financial year since 2013, equity grows to €238,663.
Annual accounts 2017 filed PDFabbreviated format · 13 days before the deadline
2017
Equity above €150,000 equity €186,167 ▲27.6% With a profit in every financial year since 2013, equity grows to €186,167.
Annual accounts 2016 filed PDFabbreviated format · 28 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 12 days before the deadline
2015
Equity above €100,000 equity €105,986 ▲40.2% With a profit in every financial year since 2013, equity grows to €105,986.
Annual accounts 2014 filed PDFabbreviated format · 8 days before the deadline
2014
Weakest financial year net €22,998 ▼47% The net result drops to €22,998, the lowest from 2013 to 2025. It recovers the following year.
Annual accounts 2013 filed PDFabbreviated format · 28 days late
2012
First establishment Baron van der Bruggenlaan 12, Wielsbeke
Incorporation PDFpublished on 23-07-2012

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 3 July 2012, DEVA PHARMA was incorporated.1 Total assets went from €911,136 in 2018 to €1.0m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps